Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Morforex

From Wikipedia, the free encyclopedia
Morforex
Clinical data
ATC code
  • None
Identifiers
  • 4-[2-[(α-Methylphenethyl)amino]ethyl]morpholine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H24N2O
Molar mass248.370 g·mol−1
3D model (JSmol)
  • CC(Cc1ccccc1)NCCN2CCOCC2
  • InChI=1S/C15H24N2O/c1-14(13-15-5-3-2-4-6-15)16-7-8-17-9-11-18-12-10-17/h2-6,14,16H,7-13H2,1H3
  • Key:ISEKMORYCCULAL-UHFFFAOYSA-N

Morforex (INN; Bo 637), also referable to as N-morpholinoethylamphetamine, is an anorectic which was never marketed.[1][2]

It produces amphetamine as an active metabolite.[3]

Synthesis

[edit]
Patent:[4]

Amphetamine is reacted with N-Chloroethylmorpholine [3240-94-6] in the presence of IPA solvent.

See also

[edit]

References

[edit]
  1. Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1377–. ISBN 978-0-412-46630-4.
  2. World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0.
  3. Goodwin BL (10 November 2004). Handbook of Biotransformations of Aromatic Compounds. CRC Press. pp. 13–. ISBN 978-0-203-64196-5.
  4. FR 2199M, "N-morpholino-1 n-phénylisopropylamino-2 éthane [N-morpholino-1 N-phenylisopropylamino-2 ethane]", published 1963-12-09, assigned to Brevets Pharmaceutiques et Cosmetologiques